ES2078519T3 - Acidos hidroxamicos ciclicos y su uso. - Google Patents

Acidos hidroxamicos ciclicos y su uso.

Info

Publication number
ES2078519T3
ES2078519T3 ES91908579T ES91908579T ES2078519T3 ES 2078519 T3 ES2078519 T3 ES 2078519T3 ES 91908579 T ES91908579 T ES 91908579T ES 91908579 T ES91908579 T ES 91908579T ES 2078519 T3 ES2078519 T3 ES 2078519T3
Authority
ES
Spain
Prior art keywords
hydrogen
hydroxamic acids
lower alkyl
cyclic hydroxamic
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91908579T
Other languages
English (en)
Inventor
Reijo Backstrom
Erkki Honkanen
Atso Raasmaja
Inge-Britt Linden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Application granted granted Critical
Publication of ES2078519T3 publication Critical patent/ES2078519T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Earth Drilling (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

ACIDOS HIDROXAMICOS CICLICOS SUBSTITUIDOS CON LA FORMULA GENERAL (I) EN DONDE R1, R2 Y R3 SON, INDEPENDIENTEMENTE, HIDROGENO, HALOGENO, ALQUILO INFERIOR, ALCOXI INFERIOR, CICLOALCOXI, ARILOXI QUE SE SUBSTITUYE OPCIONALMENTE POR 1 A 3 HALOGENO, O ARALQUILOXI, QUE SE SUBSTITUYE OPCIONALMENTE POR 1 A 3 HALOGENO, O R1 Y R2 JUNTOS FORMAN UN GRUPO -O-CH2-O-; CON LA CONDICION DE QUE R3 NO SEA HIDROGENO CUANDO R1 Y R2 SON AMBOS HIDROGENO; R4 Y R5 SON INDEPENDIENTEMENTE HIDROGENO O ALQUILO INFERIOR, R6 ES HIDROGENO O ALQUILO INFERIOR Y SUS SALES Y ESTERES FISIOLOGICAMENTE ACEPTABLES SON INHIBIDORES SELECTIVOS DE ACTIVIDAD DE LA FOSFODIESTERASA IV Y DE LA SINTESIS DE LEUCOTRIENO B4 Y C4 SIN MOSTRAR EFECTO SIGNIFICATIVO ALGUNO EN LA ACTIVIDAD DE LA FOSFODIESTERASA III Y, POR LO TANTO, SON UTILES EN EL TRATAMIENTO DE LAS ENFERMEDADES DE HIPERSENSIBILIDAD E INFLAMATORIAS.
ES91908579T 1990-04-26 1991-04-26 Acidos hidroxamicos ciclicos y su uso. Expired - Lifetime ES2078519T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909009395A GB9009395D0 (en) 1990-04-26 1990-04-26 Cyclic hydroxamic acids and their use

Publications (1)

Publication Number Publication Date
ES2078519T3 true ES2078519T3 (es) 1995-12-16

Family

ID=10675035

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91908579T Expired - Lifetime ES2078519T3 (es) 1990-04-26 1991-04-26 Acidos hidroxamicos ciclicos y su uso.

Country Status (13)

Country Link
US (1) US5356923A (es)
EP (1) EP0526535B1 (es)
JP (1) JP3227155B2 (es)
AT (1) ATE128462T1 (es)
AU (1) AU7777491A (es)
DE (1) DE69113455T2 (es)
DK (1) DK0526535T3 (es)
ES (1) ES2078519T3 (es)
FI (1) FI100052B (es)
GB (1) GB9009395D0 (es)
GR (1) GR3017821T3 (es)
WO (1) WO1991016303A1 (es)
ZA (1) ZA912886B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234933A (en) * 1991-10-31 1993-08-10 Board Of Governors Of Wayne State University And Vanderbilt University Cyclic hydroxamic acids
CA2114114C (en) * 1992-06-15 2005-05-03 Nigel Robert Arnold Beeley Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors
ZA945609B (en) 1993-07-28 1995-05-12 Rhone Poulenc Rorer Ltd [Di(ether or thioether)heteroaryl or fluoro substituted aryl] compounds
US5665754A (en) * 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines
US5502072A (en) * 1993-11-26 1996-03-26 Pfizer Inc. Substituted oxindoles
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives
WO2003032981A1 (en) 2001-10-16 2003-04-24 Memory Pharmaceuticals Corporation 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
US7696198B2 (en) 2003-04-16 2010-04-13 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
WO2006044955A1 (en) 2004-10-20 2006-04-27 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
CN102491929B (zh) * 2011-12-08 2014-04-30 贵州省中国科学院天然产物化学重点实验室 1-羟基-2-吡咯烷酮类化合物及其制备方法和应用
CN110407681B (zh) * 2019-08-12 2023-05-02 海南大学 一种脱氢姜酮衍生物、其制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193926A (en) * 1974-03-20 1980-03-18 Schering Aktiengesellschaft 4-(Polyalkoxy phenyl)-2-pyrrolidones
DE2413935A1 (de) * 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
LU85404A1 (fr) * 1984-06-06 1986-01-24 Continental Pharma Derives d'acides hydroxamiques cycliques,leur preparation et utilisation ainsi que les compositions contenant ces derives
JP2559699B2 (ja) * 1985-03-16 1996-12-04 ザ ウエルカム フアウンデ−シヨン リミテツド 新規なアリ−ル誘導体
GB8531839D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
IE59397B1 (en) * 1985-03-16 1994-02-23 Wellcome Found New aryl derivatives

Also Published As

Publication number Publication date
WO1991016303A1 (en) 1991-10-31
US5356923A (en) 1994-10-18
DE69113455T2 (de) 1996-03-21
EP0526535B1 (en) 1995-09-27
ATE128462T1 (de) 1995-10-15
FI924839A0 (fi) 1992-10-23
JPH05506236A (ja) 1993-09-16
GB9009395D0 (en) 1990-06-20
GR3017821T3 (en) 1996-01-31
DE69113455D1 (de) 1995-11-02
FI924839A7 (fi) 1992-10-23
JP3227155B2 (ja) 2001-11-12
FI100052B (fi) 1997-09-15
ZA912886B (en) 1992-01-29
EP0526535A1 (en) 1993-02-10
DK0526535T3 (da) 1995-11-27
AU7777491A (en) 1991-11-11

Similar Documents

Publication Publication Date Title
NL971014I2 (nl) Heterocyclische verbindingen.
ES2108700T3 (es) Derivados de diazabiciclonolilo como antagonistas del receptor 5-ht3.
ES2021027T5 (es) Un procedimiento para producir un compuesto de piridinsulfonamida sustituido.
ES2029812T3 (es) Un procedimiento para preparar alfa-alquil-4-amino-3-quinolina-metanoles y 1-(4-aralquilamino-3-quinolil)alcanonas.
ES2062974T3 (es) Compuestos de cefalosporina, procedimientos para su preparacion y agentes antibacterianos.
FI865269A0 (fi) Kvaevehaltiga heterocykliska foereningar.
ES2031513T3 (es) Quinazolindionas y piridopirimidinadionas.
ES2061756T3 (es) Complejos de platino (ii), su preparacion y uso como agentes anti-tumor.
ES2066808T3 (es) Derivados de quinoleina, su produccion y uso.
ES2054045T3 (es) Benzodiazepinas, su procedimiento e intermediarios de preparacion y sus aplicaciones en terapeutica.
ES2098158T3 (es) Derivados de imidazo(1,2-a)pirazina-4-ona, utiles como antagonistas de los receptores ampa y nmda.
ES2118333T3 (es) Derivados del acido naftilacetico como agonistas y antagonistas de pgez.
ES2123873T3 (es) Pirrolocarbazol.
ES2191180T3 (es) Antagonistas de los receptores de la dopamina benzoxazinona d4.
ES2150684T3 (es) Derivados de piperazina y su utilizacion como antagonistas 5-ht1a.
FR2635780B1 (fr) Diorganopolysiloxane a fonction benzotriazole
DK226285D0 (da) Beta-lactamforbindelser, deres fremstilling og anvendelse som laegemidler eller vaekstfremmende midler til dyr samt mellemprodukter til fremstillingen
ES8507536A1 (es) Un procedimiento para la preparacion de estimulantes cardiacos de quinazolinas.
DK138488A (da) Imidazolderivater
ATE128462T1 (de) Cyclische hydroxamsaeuren und ihre verwendung.
ES2076215T3 (es) Nuevos derivados de imidazol.
ES2053865T5 (es) Utilizacion de compuestos etanosulfonicos 2-substituidos como productos galvanotecnicos auxiliares.
ES8802489A1 (es) Procedimiento para la obtencion de benzamidas
ES2021621B3 (es) Amidas del acido 1 on asi como su utilizacion como reguladores del crecimiento.
ES2058569T3 (es) Derivados de la fenotiazina analgesicas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 526535

Country of ref document: ES